APA (7th ed.) Citation

Q, L., T, S., P, G., A, S., C, D. F., R, F., . . . E, M. (2026). Parametric Cardiac Imaging with 18F-Flutemetamol PET to Evaluate the Impact of Tafamidis in Patients with Transthyretin Cardiac Amyloidosis. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 67(5), 780. https://doi.org/10.2967/jnumed.125.270003

Chicago Style (17th ed.) Citation

Q, Liu, et al. "Parametric Cardiac Imaging with 18F-Flutemetamol PET to Evaluate the Impact of Tafamidis in Patients with Transthyretin Cardiac Amyloidosis." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 67, no. 5 (2026): 780. https://doi.org/10.2967/jnumed.125.270003.

MLA (9th ed.) Citation

Q, Liu, et al. "Parametric Cardiac Imaging with 18F-Flutemetamol PET to Evaluate the Impact of Tafamidis in Patients with Transthyretin Cardiac Amyloidosis." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 67, no. 5, 2026, p. 780, https://doi.org/10.2967/jnumed.125.270003.